Hamura, Japan

Hiroki Hamura

This inventor holds 1 USPTO granted patent. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2011.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroki Hamura: Innovator in Pain Management

Introduction

Hiroki Hamura is a notable inventor based in Hamura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic agents. His work focuses on alleviating chronic pain, especially neuropathic pain, which affects many individuals worldwide.

Latest Patents

Hiroki Hamura holds a patent for an innovative analgesic agent. This pharmaceutical preparation is designed to alleviate or treat pain, specifically chronic and neuropathic pain. The formulation includes a propionic acid-derived nonsteroidal anti-inflammatory agent, such as ibuprofen, a non-pyrazolone antipyretic analgesic agent like acetaminophen, and an opioid analgesic agent, including codeine phosphate or dihydrocodeine phosphate. The preparation is carefully balanced, containing specific parts by weight of each component to maximize efficacy while minimizing side effects.

Career Highlights

Hiroki Hamura is associated with Aska Pharmaceutical Co., Ltd., where he has been instrumental in advancing pain management solutions. His dedication to research and development has led to the creation of effective pharmaceutical preparations that address the needs of patients suffering from chronic pain.

Collaborations

Hiroki has collaborated with esteemed colleagues, including Hashime Kanazawa and Kenji Shimizu. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Hiroki Hamura's contributions to the field of pain management through his patented analgesic agent highlight his commitment to improving patient care. His work continues to influence the pharmaceutical industry and offers hope to those suffering from chronic pain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…